Shimmer tackling COVID-19
How Shimmer’s BioImp can help manage COVID-19
The Shimmer3 ECG/Bioimpedance Sensor is now being used to monitor the progression of COVID-19
by continuously monitoring HR, Bioimpedance, and Motion.
Want to learn more about this?
Introducing Verisense
Verisense® is the one wearable sensing platform that provides sponsors of clinical trials with a comprehensive and flexible solution to capture accurate and complete biometric data reliably and with minimum patient, site and sponsor burden. Unlike other sensing providers, Verisense has been designed from the ground up to meet the needs of clinical trials.
Verisense IMU sensor worn on the wrist
Key Benefits
Verisense solves the current issues standard wearables encounter when it comes to clinical trials, such as:
Provides continuous raw data
24/7 data coverage
No recharging for up to 6 months
No need to remove – even for bathing
Minimum burden for sites and participants
Multiple features to ensure data integrity
Advanced remote management features
“Our technology was designed specifically for use in clinical trials and differs in several significant aspects from typical off-the-shelf fitness trackers. Research staff can remotely monitor patients’ activity and sleep levels, check whether patients are wearing their device, monitor sensor battery status, and reduce the amount of patient-researcher time required to run the clinical study”
— Geoffrey Gill, Verisense Product Lead
Activity and sleep sensor for 24/7 remote patient monitoring
Verisense is designed for minimum participant and sponsor burden.
Our no-touch design ensures minimum burden and maximum compliance, leading to high quality and complete biometric data.
Verisense solves the current issues standard wearables encounter when it comes to clinical trials.
It is water and impact resistant, has up to 6 month battery life, and can be worn 24/7. This allows for continuous remote patient monitoring, more complete data and minimum burden on your trial participant.